Scientists turn benign virus into good gene therapy carrier for cystic fibrosisFebruary 17th, 2009 - 5:33 pm ICT by ANI
Washington, February 17 (ANI): A collaborative study led by scientists from the University of California, Berkeley, and the University of Iowa has led to the conversion of a relatively benign virus into a highly infectious form, which is ideal as a carrier for gene therapy.
The researchers have revealed that the first gene therapy has been found to completely cure human cystic fibrosis lung tissue in culture.
Writing about their achievement in the online early edition of the journal Proceedings of the National Academy of Sciences, the researchers said that their success with the benign adeno-associated virus (AAV) overcomes a major problem of earlier virus-based gene therapy for cystic fibrosis, and sets the stage for tests in advanced animal models of the disease.
“I think it is worthwhile thinking about clinical therapy at the levels of infection we are achieving,” said co-author David Schaffer, professor of chemical engineering at UC Berkeley.
Schaffer’’s pulmonologist colleague Joseph Zabner, who developed a new pig model of cystic fibrosis last year at the University of Iowa Hospitals and Clinics in Iowa City, has revealed that this model will provide a key test of the virus as a carrier of a gene to replace the mutated gene responsible for the disease.
“If we are able to show that efficient gene transfer can result in gene therapy, if we can cure the lung disease of pigs that have been genetically engineered to have cystic fibrosis lung disease, we should have a real chance of curing cystic fibrosis in humans,” Zabner said in an e-mail.
Schaffer and his colleagues are also joining forces with researchers elsewhere to adapt the virus to gene therapy for other diseases, including Alzheimer’’s disease and amyotrophic lateral sclerosis (Lou Gehrig’’s disease).
“Both of those are situations where improvements in the properties of the vehicle can have a significant impact on the success of the therapy,” Schaffer said.
Cystic fibrosis (CF) is a common hereditary disease that affects the body’’s mucus membranes, in particular the lungs, resulting in difficulty breathing and typically in death before the age of 40 from lung or organ failure. One in 4,000 children in the United States is born with CF.
Schaffer and his UC Berkeley colleagues collaborated with Zabner’’s laboratory to test a technique developed by Schaffer to force the evolution of a virus in ways that make it more effective in gene therapy. (ANI)
- Growth defects in patients with cystic fibrosis 'may start before birth' - Nov 10, 2010
- Boffins come closer to understanding how cystic fibrosis causes lung disease - Apr 29, 2010
- Crosstalk between ion channels leads to new therapeutic strategy - Sep 20, 2010
- Drug targets defective protein that causes cystic fibrosis - Nov 18, 2010
- Common cold virus may help treat cystic fibrosis - Jul 21, 2009
- Genetically modified 'sick pigs' created to cure human diseases - Jun 17, 2010
- Human lungs can sweep out intruders - Aug 26, 2012
- Promising results of gene therapy to treat eye diseases - Aug 14, 2010
- New bacterial foe in cystic fibrosis identified - Oct 02, 2010
- Novel drug may benefit cystic fibrosis patients - Dec 18, 2010
- Infliximab treatment effective for cystic fibrosis and Crohn's disease - Apr 20, 2010
- Boffins turn to pigs to find cystic fibrosis treatment - Sep 26, 2008
- Protein involved in cystic fibrosis linked to chronic lung diseases - Dec 30, 2010
- Scientists one step closer to a drug treatment for cystic fibrosis - Oct 13, 2010
- Vitamin D may prevent or treat allergy to common mould - Aug 17, 2010
Tags: adeno associated virus, amyotrophic lateral sclerosis, animal models, cystic fibrosis, david schaffer, gene therapy, journal proceedings, key test, lateral sclerosis lou, lou gehrig, lung tissue, national academy of sciences, new pig, proceedings of the national academy, proceedings of the national academy of sciences, pulmonologist, uc berkeley, university of california berkeley, university of iowa hospitals, university of iowa hospitals and clinics